Zoetis Inc has a consensus price target of $201.71, established from looking at the 51 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, Stifel, and Barclays on May 6, 2024, April 30, 2024, and April 23, 2024. With an average price target of $202 between Goldman Sachs, Stifel, and Barclays, there's an implied 21.72% upside for Zoetis Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Zoetis (NYSE: ZTS) was reported by Goldman Sachs on May 6, 2024. The analyst firm set a price target for $196.00 expecting ZTS to rise to within 12 months (a possible 18.11% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Zoetis (NYSE: ZTS) was provided by Goldman Sachs, and Zoetis maintained their buy rating.
There is no last upgrade for Zoetis.
The last downgrade for Zoetis Inc happened on July 16, 2021 when Raymond James changed their price target from N/A to N/A for Zoetis Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zoetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zoetis was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
While ratings are subjective and will change, the latest Zoetis (ZTS) rating was a maintained with a price target of $223.00 to $196.00. The current price Zoetis (ZTS) is trading at is $165.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.